000			03289nam a2200325 i 4500
999			_c402194 _d402194
001			402194
003			ES-MaUEC
005			20240606145123.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230130s2023 si | fo |||| 0|eng d
020			_a9789811964428
024	7		_a10.1007/978-981-19-6442-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC849 _b2023 EB
245	0	0	_aGallbladder Cancer : _bCurrent Treatment Options _cedited by Vijay Kumar Shukla, Manoj Pandey, Ruhi Dixit
250			_a1st ed. 2023
264		1	_aSingapore _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aGallbladder Cancer: Current treatment options and therapeutics -- Surgical Management of Gallbladder Cancer Patients -- Conventional therapy in Gallbladder Cancer -- Adjuvant Therapy following Surgical Treatment of Gallbladder Cancer -- Incidental gallbladder cancer: the role of routine versus selective histopathological examination of gallbladder specimens after cholecystectomy -- Minimally Invasive Surgery for Management of Gallbladder Cancer -- Thickwalled Gallbladder: Differential diagnosis and surgical approach to a thickened gallbladder -- Management of incidentally detected gallbladder cancer after cholecystectomy -- Adjuvant treatment in radically resected gallbladder cancer -- A look at emerging therapeutic targets for gallbladder cancer: a multi-omics approach -- MicroRNA and their role in Carcinoma Gallbladder -- Gallbladder cancer: Epigenetic landscape, Targeted therapy and Prospect of Epitherapy -- Targeted treatment of Gallbladder cancer -- Molecular pathways in Gallbladder cancer aspotential therapeutic target -- Targeted Therapy: Molecular Pathology and Targets of Gallbladder Cancer -- Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives -- Integrative omics - the roadmap for gallbladder biomarkers identification -- Anti-EGFR Therapy in Gall Bladder Cancer.
520			_aThe book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician.
988			_aSpringer_Medicine_2023
650		7	_2embne _9676621 _aVesícula biliar _xEnfermedades
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-6442-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2024 _dz _eb _zSI